Michael Stark/LinkedIn
Jun 26, 2026, 01:48
Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates
Michael Stark, Professor of Neonatal Medicine and Deputy Director of Clinical Research at the Robinson Research Institute, Director of Neonatal Medicine at the University of Adelaide and Head of Neonatal Services at the Women’s and Children’s Hospital Adelaide, shared a post on LinkedIn:
“For those us who thought the pinnacle of scientific poster design was reached by Australia’s own Prof Brett Manley at PAS 2026 for the PLUSS trial 2 year follow up take a look at this – not heaps of neonatal work at ISBT in Kuala Lumpur but the bar has been raised.”
Stay updated with Hemostasis Today.
-
Aug 10, 2026, 13:06Azin Kheirkhah: New Research on OSE-IgM Antibodies and Age-Related Macular Degeneration
-
Aug 10, 2026, 11:20Jean-Jacques Kiladjian: Interferon-Alpha in Polycythemia Vera Balancing Efficacy and Autoimmune Risk
-
Aug 10, 2026, 11:19Rishdha Roshad: Hemodilution vs Transfusion on CPB – Balancing Oxygen Delivery and Microcirculatory Flow
-
Aug 10, 2026, 11:15Julie McMullen: CSANZ Heart Failure Stream – Latest Updates on Atrial Myopathy and AFib
-
Aug 10, 2026, 11:07Praveen Kaudlay: A Deep Dive into Hemophilia Care Progress with Dr. Suresh Hanagavadi
-
Aug 10, 2026, 10:59Christian Heiss: Paclitaxel Efficacy in Dialysis-Dependent PAD
-
Aug 10, 2026, 10:52Seth Masters: Blocking the Effect of Pyrin by Targeting IL-1
-
Aug 10, 2026, 10:47Sadia Kamal: Making Connections and Sharing Science at Hemostasis GRC
-
Aug 10, 2026, 10:34Ifeanyichukwu Ifechidere: TTP and ADAMTS-13 – The Enzyme Deficiency That Can Kill in 24 Hours